Page last updated: 2024-11-06

benzimidazole and Helicobacter Infections

benzimidazole has been researched along with Helicobacter Infections in 2 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CS1
Liu, JF1
Lin, HJ1
Lin, CD1
Tang, CH1
Lu, DY1
Sing, YT1
Chen, LY1
Kao, MC1
Kuo, SC1
Lai, CH1
Iwao, E1
Yamamoto, K1
Yokoyama, Y1
Hirayama, F1
Haga, K1

Other Studies

2 other studies available for benzimidazole and Helicobacter Infections

ArticleYear
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
    European journal of medicinal chemistry, 2012, Volume: 48

    Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell

2012
Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2004, Volume: 10, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Gerbilli

2004